Paolo Parini

10.8k total citations · 1 hit paper
135 papers, 7.5k citations indexed

About

Paolo Parini is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Paolo Parini has authored 135 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Surgery, 41 papers in Molecular Biology and 35 papers in Oncology. Recurrent topics in Paolo Parini's work include Cholesterol and Lipid Metabolism (56 papers), Drug Transport and Resistance Mechanisms (32 papers) and Cancer, Lipids, and Metabolism (32 papers). Paolo Parini is often cited by papers focused on Cholesterol and Lipid Metabolism (56 papers), Drug Transport and Resistance Mechanisms (32 papers) and Cancer, Lipids, and Metabolism (32 papers). Paolo Parini collaborates with scholars based in Sweden, United States and Italy. Paolo Parini's co-authors include Paolo Garagnani, Aurelia Santoro, Claudio Franceschi, Cristina Giuliani, Bo Angelin, Jan-Ακε Gustafsson, Mats Rudling, Mats Eriksson, Knut R. Steffensen and Camilla Pramfalk and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Investigation.

In The Last Decade

Paolo Parini

131 papers receiving 7.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammaging: a new immune–metabolic viewpoint for age-related diseases

2018 2.0k citations Paolo Garagnani, Paolo Parini et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paolo Parini Sweden	42	2.7k	2.7k	1.3k	1.3k	1.3k	135	7.5k
Mats Rudling Sweden	46	2.3k 0.9×	2.5k 1.0×	1.9k 1.5×	1.5k 1.1×	1.4k 1.1×	97	7.9k
Massimiliano Ruscica Italy	49	1.7k 0.7×	2.5k 0.9×	1.3k 1.0×	915 0.7×	508 0.4×	226	7.0k
Bruno Guigas Netherlands	42	5.1k 1.9×	2.2k 0.8×	2.0k 1.5×	2.1k 1.6×	655 0.5×	117	9.0k
Youfei Guan China	60	4.4k 1.6×	1.6k 0.6×	1.7k 1.3×	1.7k 1.3×	742 0.6×	226	10.3k
Tatsuya Kondo Japan	43	3.6k 1.4×	1.2k 0.4×	1.6k 1.2×	1.6k 1.2×	703 0.6×	183	8.3k
Davide Lauro Italy	50	2.5k 0.9×	1.5k 0.6×	1.9k 1.4×	1.9k 1.4×	594 0.5×	206	7.3k
Reiko Inagi Japan	58	2.9k 1.1×	958 0.4×	1.2k 0.9×	1.4k 1.1×	626 0.5×	194	10.1k
Keun‐Gyu Park South Korea	47	3.1k 1.2×	986 0.4×	868 0.6×	1.2k 0.9×	687 0.5×	140	6.7k
Alyssa H. Hasty United States	54	3.3k 1.2×	2.7k 1.0×	1.4k 1.1×	2.6k 2.0×	685 0.5×	135	9.4k
Minho Shong South Korea	50	4.1k 1.5×	894 0.3×	1.5k 1.2×	1.5k 1.1×	1.2k 0.9×	212	8.4k

Countries citing papers authored by Paolo Parini

Since Specialization

Citations

This map shows the geographic impact of Paolo Parini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paolo Parini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paolo Parini more than expected).

Fields of papers citing papers by Paolo Parini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paolo Parini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paolo Parini. The network helps show where Paolo Parini may publish in the future.

Co-authorship network of co-authors of Paolo Parini

This figure shows the co-authorship network connecting the top 25 collaborators of Paolo Parini. A scholar is included among the top collaborators of Paolo Parini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paolo Parini. Paolo Parini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luciani, Lorenzo, Matteo Pedrelli, & Paolo Parini. (2024). Modification of lipoprotein metabolism and function driving atherogenesis in diabetes. Atherosclerosis. 394. 117545–117545. 21 indexed citations

Pramfalk, Camilla, Ahmed Osman, Matteo Pedrelli, et al.. (2022). Soat2 ties cholesterol metabolism to β-oxidation and glucose tolerance in male mice. Oxford University Research Archive (ORA) (University of Oxford). 16 indexed citations

Pramfalk, Camilla, Tomas Jakobsson, Maria Olin, et al.. (2020). Generation of new hepatocyte-like in vitro models better resembling human lipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1865(6). 158659–158659. 5 indexed citations

Pedrelli, Matteo, R Denis, Katariina Öörni, et al.. (2019). Insights From Liver‐Humanized Mice on Cholesterol Lipoprotein Metabolism and LXR‐Agonist Pharmacodynamics in Humans. Hepatology. 72(2). 656–670. 23 indexed citations

González‐Granillo, Marcela, Luísa A. Helguero, Eliana Alves, et al.. (2019). Sex-specific lipid molecular signatures in obesity-associated metabolic dysfunctions revealed by lipidomic characterization in ob/ob mouse. Biology of Sex Differences. 10(1). 11–11. 27 indexed citations

Osman, Ahmed, Karin Littmann, Ulf Gustafsson, et al.. (2018). Ezetimibe in Combination With Simvastatin Reduces Remnant Cholesterol Without Affecting Biliary Lipid Concentrations in Gallstone Patients. Journal of the American Heart Association. 7(24). e009876–e009876. 33 indexed citations

González‐Granillo, Marcela, Xidan Li, Mark Fitch, et al.. (2018). ERβ activation in obesity improves whole body metabolism via adipose tissue function and enhanced mitochondria biogenesis. Molecular and Cellular Endocrinology. 479. 147–158. 30 indexed citations

Pramfalk, Camilla, et al.. (2015). Culturing of HepG2 cells with human serum improve their functionality and suitability in studies of lipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1861(1). 51–59. 14 indexed citations

Degirolamo, Chiara, Salvatore Modica, Michèle Vacca, et al.. (2014). Prevention of spontaneous hepatocarcinogenesis in farnesoid X receptor–null mice by intestinal‐specific farnesoid X receptor reactivation. Hepatology. 61(1). 161–170. 92 indexed citations

10.

Pedrelli, Matteo, Padideh Davoodpour, Chiara Degirolamo, et al.. (2014). Hepatic ACAT2 Knock Down Increases ABCA1 and Modifies HDL Metabolism in Mice. PLoS ONE. 9(4). e93552–e93552. 24 indexed citations

11.

Kannisto, Kristina, Stefan Rehnmark, Paul Webb, et al.. (2014). The thyroid receptor β modulator GC-1 reduces atherosclerosis in ApoE deficient mice. Atherosclerosis. 237(2). 544–554. 17 indexed citations

12.

Pramfalk, Camilla, Mats Eriksson, & Paolo Parini. (2014). Role of TG-interacting factor (Tgif) in lipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1851(1). 9–12. 10 indexed citations

13.

Pramfalk, Camilla, Zhaoyan Jiang, & Paolo Parini. (2011). Hepatic Niemann–Pick C1-like 1. Current Opinion in Lipidology. 22(3). 225–230. 20 indexed citations

14.

Pramfalk, Camilla, Matteo Pedrelli, & Paolo Parini. (2010). Role of thyroid receptor β in lipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(8). 929–937. 44 indexed citations

15.

Björkhem‐Bergman, Linda, et al.. (2010). Lovastatin prevents carcinogenesis in a rat model for liver cancer. Effects of ubiquinone supplementation.. PubMed. 30(4). 1105–12. 38 indexed citations

16.

Sasso, Giuseppe Lo, Nicola Celli, Mariaelena Caboni, et al.. (2009). Down‐regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes†. Hepatology. 51(4). 1334–1344. 61 indexed citations

17.

Jiang, Zhaoyan, Chongyi Jiang, Jiancheng Wang, et al.. (2008). Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients. Biochemical and Biophysical Research Communications. 379(1). 49–54. 25 indexed citations

18.

Pramfalk, Camilla, Bo Angelin, Mats Eriksson, & Paolo Parini. (2007). Cholesterol regulates ACAT2 gene expression and enzyme activity in human hepatoma cells. Biochemical and Biophysical Research Communications. 364(2). 402–409. 22 indexed citations

19.

Gnerre, Carmela, Gertrud U. Schuster, Adrian Roth, et al.. (2005). LXR deficiency and cholesterol feeding affect the expression and phenobarbital-mediated induction of cytochromes P450 in mouse liver. Journal of Lipid Research. 46(8). 1633–1642. 25 indexed citations

20.

Pramfalk, Camilla, Matthew A. Davis, Mats Eriksson, Lawrence L. Rudel, & Paolo Parini. (2005). Control of ACAT2 liver expression by HNF1. Journal of Lipid Research. 46(9). 1868–1876. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact